- Investing Ideas
- /
- U.S. Healthcare Undervalued Stocks Based On Cash Flows
U.S. Healthcare Undervalued Stocks Based On Cash Flows
Results
10
2 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
10 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PRVA | US$22.69 | 0.7% | 11.8% | US$2.8b | US$26.00 | PE212.3x | E34.2% | n/a | ||
HIMS New | US$40.47 | 19.2% | 310.9% | US$9.2b | US$26.20 | PE87.3x | E15.7% | n/a | ||
HQY | US$112.07 | 1.4% | 43.6% | US$9.7b | US$114.29 | PE100.4x | E42.2% | n/a | ||
LFMD | US$6.38 | 11.5% | 11.7% | US$273.7m | US$11.72 | PS1.4x | E115.3% | n/a | ||
DXCM | US$88.32 | 0.8% | -30.5% | US$34.7b | US$97.51 | PE50.7x | E16.7% | n/a | ||
ZYXI | US$7.92 | -2.0% | -35.6% | US$254.4m | US$17.50 | PE52.3x | E38.5% | n/a | ||
PNTG | US$27.22 | -0.9% | 74.7% | US$973.8m | US$36.00 | PE44.2x | E23.8% | n/a | ||
SLP | US$35.58 | 3.8% | -12.7% | US$727.1m | US$49.40 | PE87x | E32.1% | 0% | ||
INSP | US$181.21 | -6.9% | -10.3% | US$5.8b | US$238.80 | PE164.3x | E31.0% | n/a | ||
IRTC New | US$108.55 | 0.8% | -10.3% | US$3.5b | US$110.67 | PS6.1x | E63.5% | n/a |
Page 1 of 1